{"nct_id":"NCT04501276","title":"A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-08","start_date":"2020-09-23","start_date_type":"ACTUAL","primary_completion_date":"2024-01-17","primary_completion_date_type":"ACTUAL","completion_date":"2025-02-01","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["ADAG"]}